Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000290047 | SCV000393995 | uncertain significance | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000290047 | SCV004411520 | uncertain significance | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the PSTPIP1 gene. It does not directly change the encoded amino acid sequence of the PSTPIP1 protein. It affects a nucleotide within the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 317173). This variant has not been reported in the literature in individuals affected with PSTPIP1-related conditions. This variant is present in population databases (rs749862420, gnomAD 0.007%). |